World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
30534
World Ranking
9386
National Ranking
106

Filip K. Knop publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Filip K. Knop sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 637 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Filip K. Knop D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Filip K. Knop sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Filip K. Knop is affiliated with the University of Copenhagen in Denmark and has a substantial research output primarily in the field of Medicine, with a strong focus on Endocrinology, Diabetes, and Metabolism. Their work spans subfields including Surgery, Molecular Biology, Physiology, and Epidemiology, reflecting a multidisciplinary approach to their research topics.

The main topics covered in Knop's research encompass Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic Function and Diabetes, Diet and Metabolism Studies, Metabolism related to Diabetes and Cancer, Liver Disease Diagnosis and Treatment, and Diabetes and Associated Disorders. These thematic areas reveal a focus on metabolic diseases and their management, with emphasis on both clinical and physiological aspects.

Knop has contributed to various scientific journals, with frequent publications in the following venues:

  • Diabetes
  • Diabetes Obesity and Metabolism
  • European Journal of Endocrinology
  • The Journal of Clinical Endocrinology & Metabolism
  • Diabetologia

A selection of recent papers authored or co-authored by Knop includes:

  • Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial, 2023, The Lancet

Knop frequently collaborates with several researchers, notably:

  • Tina Vilsbøll
  • Jens J. Holst
  • Bolette Hartmann
  • Asger Lund
  • Mikkel Christensen

Best Publications

  • Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

    Tina Vilsbøll;Mikkel Christensen;Anders E Junker;Filip K Knop

  • Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

    Ruud S. Kootte;Evgeni Levin;Jarkko Salojärvi;Loek P. Smits

  • Recovery of gut microbiota of healthy adults following antibiotic exposure

    Albert Palleja;Kristian H Mikkelsen;Sofia K Forslund;Alireza Kashani

  • Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

    Anne Vrieze;Carolien Out;Susana Fuentes;Lisanne Jonker

  • Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

    P. V. Højberg;P. V. Højberg;T. Vilsbøll;R. Rabøl;F. K. Knop

  • Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Filip K. Knop;Tina Vilsbøll;Patricia V. Højberg;Steen Larsen

  • Glucagon-like peptide 1 in health and disease.

    Andreas Andersen;Asger Lund;Filip K. Knop;Tina Vilsbøll

  • Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

    Mikkel Christensen;Louise Vedtofte;Jens J. Holst;Tina Vilsbøll

  • The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.

    Kristine J. Hare;Tina Vilsbøll;Meena Asmar;Carolyn F. Deacon

  • The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

    T. Vilsbøll;F. K. Knop;T. Krarup;A. Johansen

  • Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

    Jens J. Holst;Filip K. Knop;Tina Vilsbøll;Thure Krarup

  • Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

    S. Calanna;S. Calanna;M. Christensen;J. J. Holst;B. Laferrère

  • 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.

    Katrine B. Hansen;Mette M. Rosenkilde;Filip K. Knop;Niels Wellner

  • Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes

    Jonatan I. Bagger;Filip K. Knop;Asger Lund;Henrik Vestergaard

  • Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

    Heidi Storgaard;Lise L. Gluud;Cathy Bennett;Magnus F. Grøndahl

  • Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

    F. K. Knop;T. Vilsbøll;S. Madsbad;J. J. Holst

  • Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.

    Lili Niu;Lili Niu;Philipp E Geyer;Philipp E Geyer;Nicolai J Wewer Albrechtsen;Lise L Gluud

  • Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

    F K Knop;K Aaboe;T Vilsbøll;Anders Vølund

  • The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

    Asger Lund;Tina Vilsbøll;Jonatan I. Bagger;Jens J. Holst

  • The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

    Astrid Plamboeck;Simon Veedfald;Carolyn F. Deacon;Bolette Hartmann

Frequent Co-Authors

Jens J. Holst
Jens J. Holst University of Copenhagen
Sten Madsbad
Sten Madsbad University of Copenhagen
Jens F. Rehfeld
Jens F. Rehfeld University of Copenhagen
Mette M. Rosenkilde
Mette M. Rosenkilde University of Copenhagen
Carolyn F. Deacon
Carolyn F. Deacon University of Copenhagen
Lise Lotte Gluud
Lise Lotte Gluud University of Copenhagen
Torben Hansen
Torben Hansen University of Copenhagen
Lone Skov
Lone Skov University of Copenhagen
Gunnar H. Gislason
Gunnar H. Gislason Copenhagen University Hospital
Matthias Mann
Matthias Mann Max Planck Institute of Biochemistry

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine isn’t limited to becoming a doctor. There are many related online degrees and flexible career pathways that can complement or diversify your future in healthcare.

Advanced nurses looking to step into leadership or specialized clinical roles should consider the best dnp programs online. These affordable online programs offer doctorate-level training for those seeking career advancement in nursing.

For those interested in the pharmaceutical field, online pharmacy school programs offer a route to reach the top of pharmacy practice and research, with flexible schedules suitable for working professionals.

If you’re drawn towards health data, enrolling in online rhit degree programs can prepare you for roles in medical records and health information management—an area crucial to modern healthcare systems.

Finally, those looking for accessible and in-demand roles should consider a low cost medical coding and billing online program. This affordable path leads to rapid job opportunities in clinics, hospitals, and insurance organizations.

Best Scientists Citing Filip K. Knop

Trending Scientists

Recently Published Articles